One Bio (ONBI) Stock Price
One Bio Price
Over the last 4 years One Bio grew revenue by 298.7% annually, reaching 52.30 M USD. Earnings per share have grown at 17.8% per year over the last 2 years. For One Bio, the net margin of 16.6% is up versus -1.9% a few years ago. The stock trades about 150% above its 52-week low.
One Bio stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of One Bio over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how One Bio stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing One Bio's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | One Bio Price |
|---|---|
| 7/9/2026 | 0.00 USD |
| 7/8/2026 | 0.00 USD |
| 7/7/2026 | 0.00 USD |
| 7/6/2026 | 0.00 USD |
| 7/2/2026 | 0.00 USD |
| 7/1/2026 | 0.00 USD |
| 6/30/2026 | 0.00 USD |
| 6/29/2026 | 0.00 USD |
| 6/26/2026 | 0.00 USD |
| 6/25/2026 | 0.00 USD |
| 6/24/2026 | 0.00 USD |
| 6/23/2026 | 0.00 USD |
| 6/22/2026 | 0.00 USD |
| 6/18/2026 | 0.00 USD |
| 6/17/2026 | 0.00 USD |
| 6/16/2026 | 0.00 USD |
| 6/15/2026 | 0.00 USD |
| 6/12/2026 | 0.00 USD |
| 6/11/2026 | 0.00 USD |
| 6/10/2026 | 0.00 USD |
| 6/9/2026 | 0.00 USD |
| 6/8/2026 | 0.00 USD |
| 6/5/2026 | 0.00 USD |
| 6/4/2026 | 0.00 USD |
| 6/3/2026 | 0.00 USD |
| 6/2/2026 | 0.00 USD |
| 6/1/2026 | 0.00 USD |
| 5/29/2026 | 0.00 USD |
| 5/28/2026 | 0.00 USD |
| 5/27/2026 | 0.00 USD |
| 5/26/2026 | 0.00 USD |
| 5/22/2026 | 0.00 USD |
| 5/21/2026 | 0.00 USD |
| 5/20/2026 | 0.00 USD |
| 5/19/2026 | 0.00 USD |
| 5/18/2026 | 0.00 USD |
| 5/15/2026 | 0.00 USD |
| 5/14/2026 | 0.00 USD |
| 5/13/2026 | 0.00 USD |
| 5/12/2026 | 0.00 USD |
| 5/11/2026 | 0.00 USD |
| 5/8/2026 | 0.00 USD |
| 5/7/2026 | 0.00 USD |
| 5/6/2026 | 0.00 USD |
| 5/5/2026 | 0.00 USD |
| 5/4/2026 | 0.00 USD |
| 5/1/2026 | 0.00 USD |
| 4/30/2026 | 0.00 USD |
| 4/29/2026 | 0.00 USD |
| 4/28/2026 | 0.00 USD |
| 4/27/2026 | 0.00 USD |
| 4/24/2026 | 0.00 USD |
| 4/23/2026 | 0.00 USD |
| 4/22/2026 | 0.00 USD |
| 4/21/2026 | 0.00 USD |
| 4/20/2026 | 0.00 USD |
| 4/17/2026 | 0.00 USD |
| 4/16/2026 | 0.00 USD |
| 4/15/2026 | 0.00 USD |
| 4/14/2026 | 0.00 USD |
| 4/13/2026 | 0.00 USD |
| 4/10/2026 | 0.00 USD |
| 4/9/2026 | 0.00 USD |
| 4/8/2026 | 0.00 USD |
| 4/7/2026 | 0.00 USD |
| 4/6/2026 | 0.00 USD |
| 4/2/2026 | 0.00 USD |
| 4/1/2026 | 0.00 USD |
| 3/31/2026 | 0.00 USD |
| 3/30/2026 | 0.00 USD |
| 3/27/2026 | 0.00 USD |
| 3/26/2026 | 0.00 USD |
| 3/25/2026 | 0.00 USD |
| 3/24/2026 | 0.00 USD |
| 3/23/2026 | 0.00 USD |
| 3/20/2026 | 0.00 USD |
| 3/19/2026 | 0.00 USD |
| 3/18/2026 | 0.00 USD |
| 3/17/2026 | 0.00 USD |
| 3/16/2026 | 0.00 USD |
| 3/13/2026 | 0.00 USD |
| 3/12/2026 | 0.00 USD |
| 3/11/2026 | 0.00 USD |
| 3/10/2026 | 0.00 USD |
| 3/9/2026 | 0.00 USD |
| 3/6/2026 | 0.00 USD |
| 3/5/2026 | 0.00 USD |
| 3/4/2026 | 0.00 USD |
| 3/3/2026 | 0.00 USD |
| 3/2/2026 | 0.00 USD |
| 2/27/2026 | 0.00 USD |
| 2/26/2026 | 0.00 USD |
| 2/25/2026 | 0.00 USD |
| 2/24/2026 | 0.00 USD |
| 2/23/2026 | 0.00 USD |
| 2/20/2026 | 0.00 USD |
| 2/19/2026 | 0.00 USD |
| 2/18/2026 | 0.00 USD |
| 2/17/2026 | 0.00 USD |
| 2/13/2026 | 0.00 USD |
| 2/12/2026 | 0.00 USD |
| 2/11/2026 | 0.00 USD |
| 2/10/2026 | 0.00 USD |
| 2/9/2026 | 0.00 USD |
| 2/6/2026 | 0.00 USD |
| 2/5/2026 | 0.00 USD |
| 2/4/2026 | 0.00 USD |
| 2/3/2026 | 0.00 USD |
| 2/2/2026 | 0.00 USD |
| 1/30/2026 | 0.00 USD |
| 1/29/2026 | 0.00 USD |
| 1/28/2026 | 0.00 USD |
| 1/27/2026 | 0.00 USD |
| 1/26/2026 | 0.00 USD |
| 1/23/2026 | 0.00 USD |
| 1/22/2026 | 0.00 USD |
| 1/21/2026 | 0.00 USD |
| 1/20/2026 | 0.00 USD |
| 1/16/2026 | 0.00 USD |
| 1/15/2026 | 0.00 USD |
| 1/14/2026 | 0.00 USD |
| 1/13/2026 | 0.00 USD |
| 1/12/2026 | 0.00 USD |
| 1/9/2026 | 0.00 USD |
| 1/8/2026 | 0.00 USD |
| 1/7/2026 | 0.00 USD |
| 1/6/2026 | 0.00 USD |
| 1/5/2026 | 0.00 USD |
| 1/2/2026 | 0.00 USD |
| 12/31/2025 | 0.00 USD |
| 12/30/2025 | 0.00 USD |
| 12/29/2025 | 0.00 USD |
| 12/26/2025 | 0.00 USD |
| 12/24/2025 | 0.00 USD |
| 12/23/2025 | 0.00 USD |
| 12/22/2025 | 0.00 USD |
| 12/19/2025 | 0.00 USD |
| 12/18/2025 | 0.00 USD |
| 12/17/2025 | 0.00 USD |
| 12/16/2025 | 0.00 USD |
| 12/15/2025 | 0.00 USD |
| 12/12/2025 | 0.00 USD |
| 12/11/2025 | 0.00 USD |
| 12/10/2025 | 0.00 USD |
| 12/9/2025 | 0.00 USD |
| 12/8/2025 | 0.00 USD |
| 12/5/2025 | 0.00 USD |
| 12/4/2025 | 0.00 USD |
| 12/3/2025 | 0.00 USD |
| 12/2/2025 | 0.00 USD |
| 12/1/2025 | 0.00 USD |
| 11/28/2025 | 0.00 USD |
| 11/26/2025 | 0.00 USD |
| 11/25/2025 | 0.00 USD |
| 11/24/2025 | 0.00 USD |
| 11/21/2025 | 0.00 USD |
| 11/20/2025 | 0.00 USD |
| 11/19/2025 | 0.00 USD |
| 11/18/2025 | 0.00 USD |
| 11/17/2025 | 0.00 USD |
| 11/14/2025 | 0.00 USD |
| 11/13/2025 | 0.00 USD |
| 11/12/2025 | 0.00 USD |
| 11/11/2025 | 0.00 USD |
| 11/10/2025 | 0.00 USD |
| 11/7/2025 | 0.00 USD |
| 11/6/2025 | 0.00 USD |
| 11/5/2025 | 0.00 USD |
| 11/4/2025 | 0.00 USD |
| 11/3/2025 | 0.00 USD |
| 10/31/2025 | 0.00 USD |
| 10/30/2025 | 0.00 USD |
| 10/29/2025 | 0.00 USD |
| 10/28/2025 | 0.00 USD |
| 10/27/2025 | 0.00 USD |
| 10/24/2025 | 0.00 USD |
| 10/23/2025 | 0.00 USD |
| 10/22/2025 | 0.00 USD |
| 10/21/2025 | 0.00 USD |
| 10/20/2025 | 0.00 USD |
| 10/17/2025 | 0.00 USD |
| 10/16/2025 | 0.00 USD |
| 10/15/2025 | 0.00 USD |
| 10/14/2025 | 0.00 USD |
| 10/13/2025 | 0.00 USD |
| 10/10/2025 | 0.00 USD |
| 10/9/2025 | 0.00 USD |
| 10/8/2025 | 0.00 USD |
| 10/7/2025 | 0.00 USD |
| 10/6/2025 | 0.00 USD |
| 10/3/2025 | 0.00 USD |
| 10/2/2025 | 0.00 USD |
| 10/1/2025 | 0.00 USD |
| 9/30/2025 | 0.00 USD |
| 9/29/2025 | 0.00 USD |
| 9/26/2025 | 0.00 USD |
| 9/25/2025 | 0.00 USD |
| 9/24/2025 | 0.00 USD |
| 9/23/2025 | 0.00 USD |
| 9/22/2025 | 0.00 USD |
| 9/19/2025 | 0.00 USD |
| 9/18/2025 | 0.00 USD |
| 9/17/2025 | 0.00 USD |
| 9/16/2025 | 0.00 USD |
| 9/15/2025 | 0.00 USD |
| 9/12/2025 | 0.00 USD |
| 9/11/2025 | 0.00 USD |
| 9/10/2025 | 0.00 USD |
| 9/9/2025 | 0.00 USD |
| 9/8/2025 | 0.00 USD |
| 9/5/2025 | 0.00 USD |
| 9/4/2025 | 0.00 USD |
| 9/3/2025 | 0.00 USD |
| 9/2/2025 | 0.00 USD |
| 8/29/2025 | 0.00 USD |
| 8/28/2025 | 0.00 USD |
| 8/27/2025 | 0.00 USD |
| 8/26/2025 | 0.00 USD |
| 8/25/2025 | 0.00 USD |
| 8/22/2025 | 0.00 USD |
| 8/21/2025 | 0.00 USD |
| 8/20/2025 | 0.00 USD |
| 8/19/2025 | 0.00 USD |
| 8/18/2025 | 0.00 USD |
| 8/15/2025 | 0.00 USD |
| 8/14/2025 | 0.00 USD |
| 8/13/2025 | 0.00 USD |
| 8/12/2025 | 0.00 USD |
| 8/11/2025 | 0.00 USD |
| 8/8/2025 | 0.00 USD |
| 8/7/2025 | 0.00 USD |
| 8/6/2025 | 0.00 USD |
| 8/5/2025 | 0.00 USD |
| 8/4/2025 | 0.00 USD |
| 8/1/2025 | 0.00 USD |
| 7/31/2025 | 0.00 USD |
| 7/30/2025 | 0.00 USD |
| 7/29/2025 | 0.00 USD |
| 7/28/2025 | 0.00 USD |
| 7/25/2025 | 0.00 USD |
| 7/24/2025 | 0.00 USD |
| 7/23/2025 | 0.00 USD |
| 7/22/2025 | 0.00 USD |
| 7/21/2025 | 0.00 USD |
| 7/18/2025 | 0.00 USD |
| 7/17/2025 | 0.00 USD |
| 7/16/2025 | 0.00 USD |
| 7/15/2025 | 0.00 USD |
| 7/14/2025 | 0.00 USD |
One Bio Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
One Bio Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2006 | 2007 | 2008 | 2009 | 2010 |
|---|---|---|---|---|
| – | – | 10.00 | 22.00 | 52.00 |
| – | – | – | 120.00 | 136.36 |
| – | – | 60.00 | 40.91 | 38.46 |
| 20.00 | 20.00 | 6.00 | 9.00 | 20.00 |
| – | – | 3.00 | 4.00 | 8.00 |
| – | – | – | 33.33 | 100.00 |
| 0.05 | 4.07 | 3.44 | 5.12 | 6.42 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales One Bio generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue One Bio retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare One Bio's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares One Bio has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against One Bio's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
One Bio stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
One Bio Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
One Bio business model & stock analysis
One Bio SWOT Analysis
Strengths
One Bio Corp possesses several key strengths which contribute to its competitive advantage. These strengths include:
- Advanced Research and Development: One Bio Corp's strong focus on research and development enables the company to develop innovative products and maintain a competitive edge in the biotechnology industry.
- Strong Intellectual Property Portfolio: The company holds a significant number of patents and intellectual property rights, providing protection for its innovations and technologies.
- Strategic Partnerships: One Bio Corp has established strategic alliances and partnerships with leading industry players, allowing for collaborative efforts and increased market reach.
- Strong Financial Position: The company has a solid financial foundation, with healthy cash reserves and minimal debt, enabling it to invest in growth opportunities and withstand market fluctuations.
Weaknesses
Despite its strengths, One Bio Corp faces certain weaknesses that need to be addressed in order to ensure sustained success and growth. These weaknesses include:
- Limited Product Portfolio: One Bio Corp currently has a narrow range of products in its portfolio, leaving the company vulnerable to market changes and fluctuations in demand.
- Dependence on Key Customers: The company relies heavily on a few key customers for a significant portion of its revenue, creating a potential risk if these relationships weaken or terminate.
- Limited Geographic Presence: One Bio Corp has a limited international presence, primarily focusing on domestic markets. This restricts its growth potential and exposes the company to regional market risks.
Opportunities
One Bio Corp can capitalize on various opportunities to enhance its market position and drive growth. These opportunities include:
- Emerging Biotechnology Markets: The global biotechnology industry is experiencing rapid growth, presenting opportunities for One Bio Corp to expand its products and services internationally.
- Technological Advancements: Continuous advancements in technology open doors for new discoveries and innovations, providing opportunities for One Bio Corp to develop cutting-edge solutions.
- Growing Demand for Sustainable Products: Increasing awareness and demand for eco-friendly and sustainable products create avenues for One Bio Corp to align its offerings with market trends and customer preferences.
Threats
One Bio Corp faces various threats that may impact its business operations and market position. These threats include:
- Intense Competition: The biotechnology industry is highly competitive, with numerous established and emerging players. One Bio Corp must continuously innovate and differentiate itself to withstand competition.
- Regulatory Challenges: Stringent regulations and compliance requirements in the biotechnology sector can pose challenges and delays in product development and commercialization for One Bio Corp.
- Economic Uncertainty: Fluctuations in the global economy and financial markets can impact consumer spending and investment in research and development, affecting One Bio Corp's growth opportunities.
One Bio Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
One Bio historical P/E ratio, EBIT multiple, and P/S ratio
One Bio annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
One Bio shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
One Bio stock splits
One Bio Executives and Management Board
Cris Neely
(54)Chief Financial Officer, Director · since 2009
Mr. Michael Weingarten
(56)Chairman of the Board · since 2009
Marius Silvasan
(38)Vice Chairman of the Board, President, Chief Executive Officer · since 2009
Min Zhao
(42)President, China Operations and Director · since 2009
Prof. Qingsheng Fan
(48)Independent Director
Frequently asked questions about One Bio
One Bio Corp is primarily active in the biotechnology and healthcare industries.
One Bio stock
One Bio Peer Group
One Bio Ticker
One Bio FIGI
All fundamentals and in-depth analysis of One Bio
Our stock analysis for One Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of One Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.